📣 VC round data is live. Check it out!
- Public Comps
- Integer Holdings
Integer Holdings Valuation Multiples
Discover revenue and EBITDA valuation multiples for Integer Holdings and similar public comparables like ICU Medical, MGI Tech, Minimed Group, Autobio Diagnostics and more.
Integer Holdings Overview
About Integer Holdings
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.
Founded
1997
HQ

Employees
11.4K
Website
Financials (LTM)
EV
$4B
Valuation Multiples
Start free trialInteger Holdings Financials
Integer Holdings reported last 12-month revenue of $2B and EBITDA of $396M.
In the same LTM period, Integer Holdings generated $501M in gross profit, $396M in EBITDA, and $107M in net income.
Revenue (LTM)
Integer Holdings P&L
In the most recent fiscal year, Integer Holdings reported revenue of $2B and EBITDA of $402M.
Integer Holdings is profitable as of last fiscal year, with gross margin of 27%, EBITDA margin of 22%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Integer Holdings Stock Performance
Integer Holdings has current market cap of $3B, and enterprise value of $4B.
Market Cap Evolution
Integer Holdings' stock price is $89.82.
Integer Holdings share price increased by 1.5% in the last 30 days, and decreased by 24.4% in the last year.
Integer Holdings has an EPS (earnings per share) of $3.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $3B | 0.5% | 1.5% | 3.6% | -24.4% | $3.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInteger Holdings Valuation Multiples
Integer Holdings trades at 2.4x EV/Revenue multiple, and 11.2x EV/EBITDA.
EV / Revenue (LTM)
Integer Holdings Financial Valuation Multiples
As of May 15, 2026, Integer Holdings has market cap of $3B and EV of $4B.
Integer Holdings has a P/E ratio of 28.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Integer Holdings Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Integer Holdings Margins & Growth Rates
Integer Holdings decreased revenue by 2% and EBITDA by 5% in the last fiscal year.
In the most recent fiscal year, Integer Holdings reported gross margin of 27%, EBITDA margin of 22%, and net margin of 6%.
Integer Holdings Margins
Integer Holdings Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Integer Holdings Operational KPIs
Integer Holdings' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Integer Holdings' Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Integer Holdings' Rule of X is 16% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Integer Holdings Competitors
Integer Holdings competitors include ICU Medical, MGI Tech, Minimed Group, Autobio Diagnostics, Mehow Innovative, Amplifon, Haemonetics, Medacta Group, Insight Lifetech and Carl Zeiss Meditec.
Most Integer Holdings public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.8x | 1.9x | 10.2x | 10.1x | |||
| 6.7x | 6.4x | 115.8x | 87.5x | |||
| 1.1x | 1.0x | 29.1x | 9.6x | |||
| 4.4x | 4.3x | 10.8x | 11.0x | |||
| 10.7x | 9.8x | 40.3x | 37.2x | |||
| 1.6x | 1.6x | 7.3x | 7.1x | |||
| 2.6x | 2.6x | 10.4x | 8.8x | |||
| 4.6x | 4.5x | 16.1x | 16.0x | |||
This data is available for Pro users. Sign up to see all Integer Holdings competitors and their valuation data. Start Free Trial | ||||||
Integer Holdings M&A Activity
Integer Holdings has acquired 8 companies to date.
Last acquisition by Integer Holdings was on February 20th 2025. Integer Holdings acquired VSi Parylene for $28M (EV/Revenue multiple of ).
Latest Acquisitions by Integer Holdings
| Description | VSi Parylene is a precision coating services provider specializing in parylene conformal coatings for electronics, medical devices, and aerospace components. Services include vacuum deposition for moisture and corrosion protection, plus selective ablation and stripping of polymer layers using laser technology. Facilities in the United States serve manufacturers requiring MIL-SPEC compliance. | Precision Coating is a Minnesota-based manufacturer of parylene and liquid coatings for medical devices. The company applies conformal coatings to protect implants, catheters, and surgical instruments from corrosion and wear. Serving clients in the cardiovascular, neurology, and orthopedics sectors, Precision Coating operates a Class 7 cleanroom facility in Circle Pines and holds ISO 13485 certification for quality management in medical device production. | Pulse Technologies is a Pennsylvania-based manufacturer of precision components and assemblies for medical devices. The company produces custom catheter shafts, leads, and hypotubes using nitinol, platinum-iridium, and polymer materials. Capabilities include laser welding, braid reinforcement, and coatings for cardiovascular, neuromodulation, and endoscopy applications. Serving OEMs like Medtronic and Boston Scientific, facilities in Mohnton maintain ISO 13485 certification for high-volume production. | InNeuroCo is a Miami Beach-headquartered medtech company founded in 2014. It develops neural interface devices for neurosurgery, aiding precise brain mapping and stimulation during complex procedures. The team advances products from prototypes through FDA approval and manufacturing scale-up. | |
| HQ Country | |||||
| HQ City | Denver, CO | — | Philadelphia, PA | Fort Lauderdale, FL | |
| Deal Date | 20 Feb 2025 | 3 Feb 2025 | 10 Jan 2024 | 26 Oct 2023 | |
| Valuation | $28M | $152M | $140M | $42M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Integer Holdings acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Integer Holdings Investment Activity
Integer Holdings has invested in 2 companies to date.
Latest investment by Integer Holdings was on February 24th 2020. Integer Holdings invested in Cardionomic in their $16M Undisclosed stage round (EV/Revenue multiple of ).
Latest Investments by Integer Holdings
| Description | Cardionomic is a St. Paul-based developer of neuromodulation therapy for acute decompensated heart failure. Its intranasal cervical plexus stimulator delivers targeted vagus nerve signals during short ICU sessions to boost cardiac contractility and renal perfusion. In clinical studies at sites like Mayo Clinic, the device reduced BNP levels and improved ejection fraction in end-stage patients. | Aleva Neurotherapeutics is a Lausanne-based medical device company developing implantable deep brain stimulation systems using MEMS microfabrication technology. The directSTIM platform features directional electrodes for precise targeting in Parkinson's disease and essential tremor treatments. Devices enable local field potentials recording and adaptive stimulation based on brain activity. Aleva conducted acute clinical trials at Inselspital Bern and advances toward chronic implantation studies. Founded in 2008, the ISO 13485-certified firm collaborates with neurosurgery centers in Switzerland and the United States. | Cardionomic is a St. Paul-based developer of neuromodulation therapy for acute decompensated heart failure. Its intranasal cervical plexus stimulator delivers targeted vagus nerve signals during short ICU sessions to boost cardiac contractility and renal perfusion. In clinical studies at sites like Mayo Clinic, the device reduced BNP levels and improved ejection fraction in end-stage patients. |
| HQ Country | |||
| HQ City | Minneapolis, MN | Lausanne | Minneapolis, MN |
| Deal Date | 24 Feb 2020 | 27 May 2016 | 26 Oct 2015 |
| Round | Undisclosed stage | Series C | Series A |
| Raised | $16M | $18M | $20M |
| Investors | Ascension Ventures; Cleveland Clinic; Integer Holdings; New Enterprise Associates | Banexi Ventures; BB Biotech Ventures; BioMedPartners; Integer Holdings; Initiative Capital Romandie | Cleveland Clinic; Integer Holdings; New Enterprise Associates |
| Valuation | undisclosed | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Integer Holdings investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Integer Holdings
| When was Integer Holdings founded? | Integer Holdings was founded in 1997. |
| Where is Integer Holdings headquartered? | Integer Holdings is headquartered in United States. |
| How many employees does Integer Holdings have? | As of today, Integer Holdings has over 11K employees. |
| Who is the CEO of Integer Holdings? | Integer Holdings' CEO is Payman Khales. |
| Is Integer Holdings publicly listed? | Yes, Integer Holdings is a public company listed on NYSE. |
| What is the stock symbol of Integer Holdings? | Integer Holdings trades under ITGR ticker. |
| When did Integer Holdings go public? | Integer Holdings went public in 2000. |
| Who are competitors of Integer Holdings? | Integer Holdings main competitors include ICU Medical, MGI Tech, Minimed Group, Autobio Diagnostics, Mehow Innovative, Amplifon, Haemonetics, Medacta Group, Insight Lifetech, Carl Zeiss Meditec. |
| What is the current market cap of Integer Holdings? | Integer Holdings' current market cap is $3B. |
| What is the current revenue of Integer Holdings? | Integer Holdings' last 12 months revenue is $2B. |
| What is the current revenue growth of Integer Holdings? | Integer Holdings revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Integer Holdings? | Current revenue multiple of Integer Holdings is 2.4x. |
| Is Integer Holdings profitable? | Yes, Integer Holdings is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Integer Holdings? | Integer Holdings' last 12 months EBITDA is $396M. |
| What is Integer Holdings' EBITDA margin? | Integer Holdings' last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Integer Holdings? | Current EBITDA multiple of Integer Holdings is 11.2x. |
| What is the current FCF of Integer Holdings? | Integer Holdings' last 12 months FCF is $104M. |
| What is Integer Holdings' FCF margin? | Integer Holdings' last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Integer Holdings? | Current FCF multiple of Integer Holdings is 42.3x. |
| How many companies Integer Holdings has acquired to date? | As of May 2026, Integer Holdings has acquired 8 companies. |
| What was the largest acquisition by Integer Holdings? | $220M acquisition of Oscor on 2nd December 2021 was the largest M&A Integer Holdings has done to date. |
| What companies Integer Holdings acquired? | Integer Holdings acquired Oscor, Precision Coating, Pulse Technologies, Aran Biomedical, InNeuroCo, VSi Parylene, CCC Medical Devices, and Inomec Ltd. |
| In how many companies Integer Holdings has invested to date? | As of May 2026, Integer Holdings has invested in 2 companies. |
| What was the last Integer Holdings investment? | On 24th February 2020 Integer Holdings invested in Cardionomic, participating in a $16M Undisclosed stage round, alongside Ascension Ventures, Cleveland Clinic, and New Enterprise Associates. |
| In what companies Integer Holdings invested in? | Integer Holdings invested in Cardionomic and Aleva Neurotherapeutics. |
See public comps similar to Integer Holdings
Lists including Integer Holdings
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

